Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Forero DF, Dendukuri N. A mini-health technology assessment of Linear and Radial Endobronchial Ultrasound
(EBUS) and Electromagnetic Navigation Bronchoscopy (ENB) in the diagnosis and staging
of lung cancer in adults. Montreal: Technology Assessment Unit of the McGill University Health Centre (MUHC). 2016 Authors' objectives The objective of this mini HTA is to review and summarize the most recent evidence on efficacy and
safety of all three technologies for the diagnosis and staging of lung cancer. We also report on the budget
impact of these technologies to the MUHC. Authors' conclusions There is sufficient evidence supporting the use of linear EBUS as a first-line approach for lung cancer staging.
- For investigation of peripheral nodules suspected of lung cancer, radial EBUS should be available for use at the clinician's discretion.
- There is very limited evidence supporting the usage of ENB together with R-EBUS. Therefore, this technology should be judiciously used only when the yield of radial EBUS is felt to be lower than usual and TTNA is best avoided.
- Given the residual uncertainty in patient selection and the low quality of evidence on efficacy, particularly for R-EBUS and ENB technologies, it is recommended that a prospective database be maintained that will allow the study of patient characteristics and patient outcomes that can aid decision making. Such a database has been commenced for ENB at the MUHC and should be extended to include R-EBUS and L-EBUS. Indexing Status Subject indexing assigned by CRD MeSH Adult; Bronchoscopy; Electromagnetic Phenomena; Humans; Lung Neoplasms; Solitary Pulmonary Nodule; Technology Assessment, Biomedical; Ultrasonography Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Technology Assessment Unit of the MUHC, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 boul. de Maisonneuve, Bureau 3F.50, Montreal, Quebec H4A 3S5 Email: nandini.dendukuri@mcgill.ca AccessionNumber 32017000418 Date abstract record published 06/11/2017 |